Target family: Galanin receptors (type: gpcr)
Target: GAL<sub>2</sub> receptor

Ligand: Gal-B2 (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 7.29 pKi
Reference (Journal): Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities.
Published in: J Med Chem

Ligand: Gal-B2-dPEG24 (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 7.87 pKi
Reference (Journal): Incorporation of monodisperse oligoethyleneglycol amino acids into anticonvulsant analogues of galanin and neuropeptide y provides peripherally acting analgesics.
Published in: Mol Pharm

Ligand: Gal-B2-MPEG4 (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 7.69 pKi
Reference (Journal): Structural requirements for a lipoamino acid in modulating the anticonvulsant activities of systemically active galanin analogues.
Published in: J Med Chem

Ligand: Gal-B5 (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 7.32 pKi
Reference (Journal): Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activities.
Published in: J Med Chem

Ligand: Gal-(K)4 (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 7.62 pKi
Reference (Journal): Structural requirements for a lipoamino acid in modulating the anticonvulsant activities of systemically active galanin analogues.
Published in: J Med Chem

Ligand: galmic (Synthetic organic)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 5 pKd
Reference (Journal): Galanin receptor ligands.
Published in: Neuropeptides

Ligand: galmic (Synthetic organic)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 5 pKd
Reference (Journal): Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests.
Published in: Proc Natl Acad Sci USA

Ligand: galnon (Synthetic organic)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 4.47 pKi
Reference (Journal): Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests.
Published in: Proc Natl Acad Sci USA

Ligand: galnon (Synthetic organic)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 4.47 pKi
Reference (Journal): Galanin receptor ligands.
Published in: Neuropeptides

Ligand: GALP(1-32) (human) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 7.16 pIC50
Reference (Journal): Pharmacological and functional characterization of galanin-like peptide fragments as potent galanin receptor agonists.
Published in: Neuropeptides

Ligand: GALP(3-32) (human) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 7.82 pIC50
Reference (Journal): Pharmacological and functional characterization of galanin-like peptide fragments as potent galanin receptor agonists.
Published in: Neuropeptides

Ligand: Gal-R2-dPEG24 (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 7.22 pKi
Reference (Journal): Incorporation of monodisperse oligoethyleneglycol amino acids into anticonvulsant analogues of galanin and neuropeptide y provides peripherally acting analgesics.
Published in: Mol Pharm

Ligand: GalR3ant (Synthetic organic)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity: 5 pKi
Reference (Journal): Galanin receptor ligands.
Published in: Neuropeptides

Ligand: GMAP(1-41) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 6.08 pKi
Reference (Journal): Molecular cloning and pharmacological characterization of a new galanin receptor subtype.
Published in: Mol Pharmacol

Ligand: GMAP(44-59) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 6 pKi
Reference (Journal): Cloning and expressional characterization of a novel galanin receptor. Identification of different pharmacophores within galanin for the three galanin receptor subtypes.
Published in: J Biol Chem

Ligand: J18 (galanin analogue) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 7.7 pKi
Reference (Journal): Novel systemically active galanin receptor 2 ligands in depression-like behavior.
Published in: J Neurochem

Ligand: J20 (galanin analogue) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 8.31 pKi
Reference (Journal): Novel systemically active galanin receptor 2 ligands in depression-like behavior.
Published in: J Neurochem

Ligand: M1145 (Peptide)
Interaction type: Agonist
Action: Full agonist
Ligand approved: no
Median affinity: 8.18 pKi
Reference (Journal): A novel GalR2-specific peptide agonist.
Published in: Neuropeptides

Ligand: M1151 (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 7.54 pKi
Reference (Journal): Novel galanin receptor subtype specific ligands in feeding regulation.
Published in: Neurochem Int

Ligand: M1152 (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 7.44 pKi
Reference (Journal): Novel galanin receptor subtype specific ligands in feeding regulation.
Published in: Neurochem Int

Ligand: M1153 (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 8.3 pKi
Reference (Journal): Novel galanin receptor subtype specific ligands in feeding regulation.
Published in: Neurochem Int

Ligand: M1160 (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 7.48 pKi
Reference (Journal): Novel galanin receptor subtype specific ligand in depression like behavior.
Published in: Neurochem Res

Ligand: M15 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity: 6.52 pEC50
Reference (Journal): Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover.
Published in: J Biol Chem

Ligand: M15 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity: 8.85 pKi
Reference (Journal): The mouse GalR2 galanin receptor: genomic organization, cDNA cloning, and functional characterization.
Published in: J Neurochem

Ligand: M15 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity: 8.97 pKi
Reference (Journal): Cloning and characterization of the human galanin GALR2 receptor.
Published in: Peptides

Ligand: M15 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pEC50
Reference (Journal): Cloning and expression of the human galanin receptor GalR2.
Published in: Biochem Biophys Res Commun

Ligand: M15 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pEC50
Reference (Journal): Cloning and characterization of the human galanin GALR2 receptor.
Published in: Peptides

Ligand: M15 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pEC50
Reference (Journal): Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor.
Published in: Brain Res Mol Brain Res

Ligand: M15 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity: 8.4 pIC50
Reference (Journal): Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor.
Published in: Brain Res Mol Brain Res

Ligand: M15 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Cloning and expressional characterization of a novel galanin receptor. Identification of different pharmacophores within galanin for the three galanin receptor subtypes.
Published in: J Biol Chem

Ligand: M15 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels.
Published in: J Biol Chem

Ligand: M15 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover.
Published in: J Biol Chem

Ligand: M15 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): The mouse GalR2 galanin receptor: genomic organization, cDNA cloning, and functional characterization.
Published in: J Neurochem

Ligand: M15 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pIC50
Reference (Journal): Molecular cloning and characterization of a new receptor for galanin.
Published in: FEBS Lett

Ligand: M15 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Molecular cloning and pharmacological characterization of a new galanin receptor subtype.
Published in: Mol Pharmacol

Ligand: M15 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Galanin receptor ligands.
Published in: Neuropeptides

Ligand: M15 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pIC50
Reference (Journal): Cloning, pharmacological characterization and distribution of a novel galanin receptor.
Published in: Brain Res Mol Brain Res

Ligand: M242 (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 8.23 pKi
Reference (Journal): Characterisation of a new chimeric ligand for galanin receptors: galanin(1-13)-[D-Trp(32)]-neuropeptide Y(25-36)amide.
Published in: Regul Pept

Ligand: M32 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pEC50
Reference (Journal): Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor.
Published in: Brain Res Mol Brain Res

Ligand: M32 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover.
Published in: J Biol Chem

Ligand: M32 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Primary target: no
Median affinity: 7.889999866485596 pKi
Reference (Journal): Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover.
Published in: J Biol Chem

Ligand: M32 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pEC50
Reference (Journal): Cloning and characterization of the human galanin GALR2 receptor.
Published in: Peptides

Ligand: M32 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Characterisation of a new chimeric ligand for galanin receptors: galanin(1-13)-[D-Trp(32)]-neuropeptide Y(25-36)amide.
Published in: Regul Pept

Ligand: M32 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels.
Published in: J Biol Chem

Ligand: M32 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Cloning and characterization of the human galanin GALR2 receptor.
Published in: Peptides

Ligand: M35 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity: 7.54 pEC50
Reference (Journal): Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover.
Published in: J Biol Chem

Ligand: M35 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity: 8.31 pKi
Reference (Journal): The mouse GalR2 galanin receptor: genomic organization, cDNA cloning, and functional characterization.
Published in: J Neurochem

Ligand: M35 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Cloning and expression of the human galanin receptor GalR2.
Published in: Biochem Biophys Res Commun

Ligand: M35 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Cloning and characterization of the human galanin GALR2 receptor.
Published in: Peptides

Ligand: M35 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pEC50
Reference (Journal): Cloning and characterization of the human galanin GALR2 receptor.
Published in: Peptides

Ligand: M35 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pEC50
Reference (Journal): Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor.
Published in: Brain Res Mol Brain Res

Ligand: M35 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): The mouse GalR2 galanin receptor: genomic organization, cDNA cloning, and functional characterization.
Published in: J Neurochem

Ligand: M35 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover.
Published in: J Biol Chem

Ligand: M35 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels.
Published in: J Biol Chem

Ligand: M35 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pIC50
Reference (Journal): Cloning, pharmacological characterization and distribution of a novel galanin receptor.
Published in: Brain Res Mol Brain Res

Ligand: M35 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Molecular cloning and pharmacological characterization of a new galanin receptor subtype.
Published in: Mol Pharmacol

Ligand: M35 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pIC50
Reference (Journal): Molecular cloning and characterization of a new receptor for galanin.
Published in: FEBS Lett

Ligand: M35 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Galanin receptor ligands.
Published in: Neuropeptides

Ligand: M40 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pIC50
Reference (Journal): Molecular cloning and characterization of a new receptor for galanin.
Published in: FEBS Lett

Ligand: M40 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Molecular cloning and pharmacological characterization of a new galanin receptor subtype.
Published in: Mol Pharmacol

Ligand: M40 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Galanin receptor ligands.
Published in: Neuropeptides

Ligand: M40 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pIC50
Reference (Journal): Cloning, pharmacological characterization and distribution of a novel galanin receptor.
Published in: Brain Res Mol Brain Res

Ligand: M40 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity: 7.79 pEC50
Reference (Journal): Cloning and characterization of the human galanin GALR2 receptor.
Published in: Peptides

Ligand: M40 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity: 7.55 pEC50
Reference (Journal): Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover.
Published in: J Biol Chem

Ligand: M40 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): The mouse GalR2 galanin receptor: genomic organization, cDNA cloning, and functional characterization.
Published in: J Neurochem

Ligand: M40 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover.
Published in: J Biol Chem

Ligand: M40 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels.
Published in: J Biol Chem

Ligand: M40 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Cloning and characterization of the human galanin GALR2 receptor.
Published in: Peptides

Ligand: M40 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Cloning and expressional characterization of a novel galanin receptor. Identification of different pharmacophores within galanin for the three galanin receptor subtypes.
Published in: J Biol Chem

Ligand: M40 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity:  pKi
Reference (Journal): Cloning and expression of the human galanin receptor GalR2.
Published in: Biochem Biophys Res Commun

Ligand: M40 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity: 8.55 pKi
Reference (Journal): The mouse GalR2 galanin receptor: genomic organization, cDNA cloning, and functional characterization.
Published in: J Neurochem

Ligand: M617 (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 8.24 pKi
Reference (Journal): A Galanin Receptor Subtype 1 Specific Agonist.
Published in: International Journal of Peptide Research and Therapeutics,

Ligand: M871 (Peptide)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Primary target: no
Median affinity: 7.880000114440918 pKi
Reference (Journal): M871- A Novel Peptide Antagonist Selectively Recognising the Galanin Receptor Type 2.
Published in: Int J Pept Res

Ligand: [N-Me,des-Sar]Gal-B2 (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 7.69 pKi
Reference (Journal): Engineering galanin analogues that discriminate between GalR1 and GalR2 receptor subtypes and exhibit anticonvulsant activity following systemic delivery.
Published in: J Med Chem

Ligand: Qu-SPX (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Primary target: no
Median affinity: 7.059999942779541 pEC50
Reference (Journal): Exploring the molecular structures that confer ligand selectivity for galanin type II and III receptors.
Published in: PLoS One

Ligand: [Sar1, D-Ala12]galanin(1-16) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 8.76 pIC50
Reference (Journal): Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via GalR1 and GalR2 receptors.
Published in: Proc Natl Acad Sci USA

Ligand: SNAP 37889 (Synthetic organic)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity: 5 pKi
Reference (Journal): Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299.
Published in: Proc Natl Acad Sci USA

Ligand: SNAP 398299 (Synthetic organic)
Interaction type: Antagonist
Action: Antagonist
Ligand approved: no
Median affinity: 6 pKi
Reference (Journal): Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299.
Published in: Proc Natl Acad Sci USA

Ligand: spexin-1 (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Primary target: no
Median affinity: 6.789999961853027 pEC50
Reference (Journal): Coevolution of the spexin/galanin/kisspeptin family: Spexin activates galanin receptor type II and III.
Published in: Endocrinology

Ligand: [125I]spexin-1 (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Primary target: no
Median affinity:  -
Reference (Journal): Coevolution of the spexin/galanin/kisspeptin family: Spexin activates galanin receptor type II and III.
Published in: Endocrinology

Ligand: [125I][Tyr26]galanin (human) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Primary target: no
Median affinity: 9.229999542236328 pKd
Reference (Journal): Molecular cloning and pharmacological characterization of a new galanin receptor subtype.
Published in: Mol Pharmacol

Ligand: [125I][Tyr26]galanin (human) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Primary target: no
Median affinity:  pKd
Reference (Journal): Cloning and expression of the human galanin receptor GalR2.
Published in: Biochem Biophys Res Commun

Ligand: [125I][Tyr26]galanin (human) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 9.33 pKd
Reference (Journal): The mouse GalR2 galanin receptor: genomic organization, cDNA cloning, and functional characterization.
Published in: J Neurochem

Ligand: [125I][Tyr26]galanin (human) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Primary target: no
Median affinity:  pKd
Reference (Journal): Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3.
Published in: J Neurochem

Ligand: [125I][Tyr26]galanin (pig) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity: 9.92 pKd
Reference (Journal): Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor.
Published in: Brain Res Mol Brain Res

Ligand: [125I][Tyr26]galanin (pig) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity:  pKd
Reference (Journal): Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels.
Published in: J Biol Chem

Ligand: [125I][Tyr26]galanin (pig) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Primary target: no
Median affinity: 9.510000228881836 pKd
Reference (Journal): Cloning and characterization of the human galanin GALR2 receptor.
Published in: Peptides

Ligand: [125I][Tyr26]galanin (pig) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity:  pKd
Reference (Journal): Melting of a DNA hairpin without hyperchromism.
Published in: Biochemistry

Ligand: [125I][Tyr26]galanin (pig) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity:  pKd
Reference (Journal): Molecular cloning and pharmacological characterization of a new galanin receptor subtype.
Published in: Mol Pharmacol

Ligand: [125I][Tyr26]galanin (pig) (Peptide)
Interaction type: Agonist
Action: Agonist
Ligand approved: no
Median affinity:  pKd
Reference (Journal): Cloning, pharmacological characterization and distribution of a novel galanin receptor.
Published in: Brain Res Mol Brain Res